| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000178163 |
| P698 | PubMed publication ID | 19033714 |
| P2093 | author name string | Evangelos Felekouras | |
| Antonios Papachristodoulou | |||
| Aristides Polyzos | |||
| Athanasios Giannopoulos | |||
| Gregory Kouraklis | |||
| John Griniatsos | |||
| Kostas Polyzos | |||
| Nikolas Nikiteas | |||
| Nikolas Tsavaris | |||
| John Souglakos | |||
| Christos Tsigris | |||
| Demetrios Mantas | |||
| Hellen Gogas | |||
| John G Karavokyros | |||
| Lambros Vambakas | |||
| Nikolaos Vardakas | |||
| P433 | issue | 1 | |
| P921 | main subject | oxaliplatin | Q422327 |
| P304 | page(s) | 36-41 | |
| P577 | publication date | 2008-11-26 | |
| P1433 | published in | Oncology | Q2016300 |
| P1476 | title | Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience | |
| P478 | volume | 76 |
| Q92079004 | A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia |
| Q40184667 | Atypical presentation of fever as hypersensitivity reaction to oxaliplatin |
| Q43055457 | Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions |
| Q49361085 | Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin among Colorectal Cancer Patients |
| Q38163829 | Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions |
| Q38222050 | Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators |
| Q38132699 | Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy |
| Q44080416 | Effectiveness of oxaliplatin desensitization protocols |
| Q34054701 | Hypersensitivity following Retreatment with Carboplatin a Decade after Completion of Primary Platinum-Based Chemotherapy |
| Q38259295 | Hypersensitivity reactions associated with oxaliplatin and their clinical management |
| Q38009188 | Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. |
| Q37497459 | Hypersensitivity to oxaliplatin: clinical features and risk factors. |
| Q38968266 | Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience |
| Q88288687 | Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatment |
| Q33402268 | Oxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literature |
| Q55605577 | Oxaliplatin-induced bronchiolitis obliterans organizing pneumonia following hyperthermic intraperitoneal chemotherapy. |
| Q33413179 | Oxaliplatin-induced immune-mediated cytopenias: a case report and literature review |
| Q90714746 | Platin chemotherapy hypersensitivity reactions: Expanding the scope of practice and improving care |
| Q38521636 | Platinum hypersensitivity and desensitization |
| Q38541188 | Presentation and Diagnosis of Hypersensitivity to Platinum Drugs |
| Q27021105 | Review of systemic therapies for locally advanced and metastatic rectal cancer |
Search more.